控股子公司将聚焦质谱技术领域，组织开展质谱共性技术、关键核心部件的研发，组织开展质谱新技术 验证、评价及应用推广，促进质谱行业交流合作，推动行业发展。控股子公司注册资本为1000万元，其 中雪迪龙以自有资金出资800万元，占控股子公司注册资本的80%，怀柔硬科技公司出资200万元，占控 股子公司注册资本的20%。 （文章来源：证券日报） 雪迪龙在质谱技术领域具有一定基础，已形成飞行时间质谱等系列产品，通过设立该控股子公司，对雪 迪龙在质谱技术及相关软硬件产品的布局和未来技术升级有积极作用，通过开展质谱新技术验证评价， 可更广泛、更及时地发现新技术、新产品，也可提升未来潜在的质谱相关技术、产品、人才、公司等整 合机会，促进质谱行业交流与合作，为质谱行业发展贡献力量。 8月4日晚间，北京雪迪龙科技股份有限公司（以下简称"雪迪龙"）公告称，拟与北京怀柔硬科技创新服 务有限公司（以下简称"怀柔硬科技公司"）共同出资设立控股子公司怀众质谱（北京）技术有限公司 （暂定名，以市场监督管理局核定为准，以下简称"控股子公司"）。 ...

Group 1 - The company held its 20th meeting of the 5th Board of Directors on August 4, 2025, with all 7 directors present, complying with legal and procedural requirements [1] - The board approved a proposal to invest 8 million RMB to establish a holding subsidiary focused on mass spectrometry technology, with a total registered capital of 10 million RMB [1] - The investment does not constitute a related party transaction or a major asset restructuring, and the decision was unanimously supported by all directors [2] Group 2 - The company plans to reduce its repurchased shares through centralized bidding, with a maximum of 6,357,609 shares, representing up to 1% of the total share capital [2] - The reduction period is set from August 27, 2025, to November 27, 2025, excluding any periods prohibited by regulatory authorities [2]

一、监事会会议召开情况 北京雪迪龙科技股份有限公司（下称"公司"）第五届监事会第十九次会议于2025年8 月4日（星期一）下午15:00在公司会议室，以现场与远程视频会议结合的方式召开，公司 于2025年8月4日以通讯方式发出会议通知。会议应出席监事3名，实际出席监事3名，会议 由监事会主席陈华申先生主持，本次会议的召开与表决符合《公司法》、《公司章程》和 《公司监事会议事规则》的有关规定，表决结果真实有效。 二、监事会会议审议情况 与会监事经过认真讨论，审议通过了下述议案： （一）审议通过《关于对外投资设立控股子公司的议案》； 证券代码：002658 股票简称：雪迪龙 公告编号：2025-029 北京雪迪龙科技股份有限公司 第五届监事会第十九次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 经审核，监事会认为：本次设立控股子公司所需资金为公司自有资金，投资金额为 800 万元，占公司最近一期经审计净资产的 0.31%，不会对公司财务及经营状况产生重大不利 影响，不存在损害公司及全体股东利益的情形。同意公司以自有资金 800 万元与北京怀柔 硬科 ...

Investment Overview - Beijing Xuedilong Technology Co., Ltd. plans to establish a holding subsidiary, Huazhong Mass Spectrometry (Beijing) Technology Co., Ltd., in collaboration with Beijing Huairou Hard Technology Innovation Service Co., Ltd. The subsidiary will focus on mass spectrometry technology, including the development of common technologies and key components, as well as the validation and promotion of new technologies in the mass spectrometry field [1][2][5] Investment Details - The registered capital of the holding subsidiary is set at 10 million yuan, with Xuedilong contributing 8 million yuan (80%) and Huairou Hard Technology contributing 2 million yuan (20%) [1][4] - The investment does not constitute a related party transaction or a major asset restructuring as per relevant regulations [2][7] Purpose and Impact - The establishment of the subsidiary aligns with the company's strategy and aims to strengthen its market position in the mass spectrometry industry. It is expected to facilitate the discovery of new technologies and products, enhancing the company's capabilities in mass spectrometry-related technologies and products [5][6] - The company has a foundation in mass spectrometry technology, with existing products capable of analyzing various environmental samples, which will be further developed through this investment [5][6] Governance Structure - The subsidiary will have a governance structure that includes a shareholders' meeting, a board of directors, and a general manager. The board will consist of one director recommended by Xuedilong, who will also serve as the legal representative [5][6]

Core Viewpoint - The company, Beijing Xuedilong Technology Co., Ltd., has announced a plan to reduce its repurchased shares through centralized bidding, with a maximum reduction of 6,357,609 shares, representing up to 1% of the total share capital [1][2]. Group 1: Share Repurchase and Reduction Plan - The company approved a share repurchase plan on February 6, 2024, with a total fund of no less than RMB 50 million and no more than RMB 100 million, at a maximum price of RMB 7.50 per share [1][2]. - The total number of shares repurchased by the company reached 11,243,157 shares, accounting for 1.77% of the total share capital, and the repurchase plan has been completed [2][4]. - The reduction period for the repurchased shares is set from August 27, 2025, to November 27, 2025, with the possibility of adjustments based on legal regulations [3][4]. Group 2: Impact on Share Structure - The implementation of the reduction plan will not change the company's control or total share capital, with the share structure remaining stable before and after the reduction [3][4]. - The company’s shareholding structure before and after the reduction indicates that the proportion of restricted shares and unrestricted shares will remain unchanged at 43.59% and 56.41%, respectively [3]. Group 3: Financial Implications - Funds obtained from the reduction of repurchased shares will be used to supplement the company's working capital, enhancing capital efficiency and sustaining operational capabilities [4]. - The difference between the selling price of the reduced shares and the repurchase price will be accounted for in the company's capital reserve, not affecting current profits or future development [4]. Group 4: Compliance and Governance - The company has confirmed that there were no share trading activities by directors, supervisors, senior management, or major shareholders in the six months prior to the board's decision on the reduction [4]. - The company will adhere to relevant laws and regulations during the reduction period and fulfill its information disclosure obligations [5].

据统计，8月4日，盘后包括达意隆、山外山、开普检测、吉宏股份、红旗连锁、通达股份、神火股份、 康泰医学、步科股份、飞鹿股份、能辉科技、晶雪节能、胜宏科技、赛腾股份、雪迪龙、中芯国际、工 大高科、成都先导、飞乐音响、华电辽能、三维股份、奥锐特在内的22家A股上市公司披露减持情况。 当日暂无A股上市公司披露增持情况。 | 1 | 达意障 | 董事兼高级管理人员吴小满计划减持不超过4.22万股股份 | | --- | --- | --- | | 2 | 山外山 | 大健康和力远健鲲合计减持2.26%公司股份 | | 3 | 开普检测 | 副总经理贺春、张冉拟减持不超过0.54%公司股份 | | 4 | 吉宏股份 | 毒事长干亚朋计划减持不超过304万股 | | 5 | 红旗连锁 | 永辉超市拟减持不超过1%股份 | | 6 | 通达股份 | 控股股东拟减持不超过3%公司股份 | | 1 | 神火股份 | 普天工贸拟减持0.90%公司股份 | | 8 | 康泰医学 | 持股5%以上股东及部分董事、高管拟减持不超过3.59%股份 | | 9 | 步科股份 | 控股股东上海步进计划减持不超过3%公司股份 | | 10 | ...

Group 1 - Nanjing Bank's shareholder Nanjing High-Tech increased its shareholding from 8.94% to 9% [1] - Xuedilong plans to reduce its holdings by no more than 1% of the company's total share capital [1] - Sanwei Co., Ltd.'s shareholder Chi Yao No. 10 Investment Fund intends to reduce its holdings by no more than 1% of the company's shares [1] Group 2 - Chengdu XianDao's shareholders plan to collectively reduce their holdings by no more than 5 million shares [1]

（文章来源：证券日报） 证券日报网讯 8月4日晚间，雪迪龙发布公告称，公司第五届董事会第二十次会议审议通过了《关于对 外投资设立控股子公司的议案》《关于回购股份集中竞价减持计划的议案》。 ...

证券日报网讯 8月4日晚间，雪迪龙发布公告称，公司第五届监事会第十九次会议审议通过了《关于对 外投资设立控股子公司的议案》。 （文章来源：证券日报） ...

控股子公司注册资本为1,000万元，其中公司以自有资金出资800万元，占控股子公司注册资本的 80.00%，怀柔硬科技公司出资200万元，占控股子公司注册资本的20.00%。 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不 对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担 全部责任。邮箱：news_center@staff.hexun.com 格隆汇8月4日丨雪迪龙(002658.SZ)公布，公司拟与北京怀柔硬科技创新服务有限公司(简称"怀柔硬科技 公司")共同出资设立控股子公司怀众质谱(北京)技术有限公司(暂定名，以市场监督管理局核定为准，简 称"控股子公司")。控股子公司将聚焦质谱技术领域，组织开展质谱共性技术、关键核心部件的研发， 组织开展质谱新技术验证、评价及应用推广，促进质谱行业交流合作，推动行业发展。 ...